Sartorius Stedim Biotech Introduces New Benchtop Bioreactor System

Article

The ambr 250 is a mini bioreactor system for parallel fermentation or cell culture.

On June 15, 2016, Sartorius Stedim Biotech introduced the ambr 250 mini benchtop bioreactor system for parallel fermentation or cell culture. This system combines a unique single-use bioreactor vessel and expandable system design for process development, the company said in a press announcement.

The new ambr 250 modular system consists of a workstation with two, four, six, or eight single-use bioreactors, with a working volume range of 100–250 mL. These mini bioreactors, based on the same stirred tank bioreactors in the high throughput system, contain impellers suitable for fermentation or cell culture and scale up to larger bioreactors. They are also fully integrated with liquid reservoirs and syringe pumps, allowing rapid experimental set up and turn around, thus significantly increasing lab efficiency.

Once installed, the bioreactor has all the required process services for parameter control, including pH, DO, temperature, and agitation. Feeds can also be delivered from the reagent reservoirs via syringe pumps into the bioreactor. One control unit is capable of controlling up to eight bioreactor stations independently using a touch screen user interface.

Source: Sartorius Stedim Biotech

 

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content